10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
In a development sure to be welcomed by employers, the U.S. Department of Labor (DOL) issued revised...
Read More >
Beginning on March 15, 2020, employers will have to begin providing their Pittsburgh employees with ...
Read More >
The First Circuit recently denied a corporation’s numerous arguments seeking to vacate an arbitrati...
Read More >
Retailers faced a difficult financing market before COVID-19 appeared, but lockdowns have made the s...
Read More >
On February 27, 2020, the Federal Trade Commission (FTC) announced an action to block a proposed tra...
Read More >
Massachusetts has fined Chipotle $1.4 million as part of a settlement with the restaurant chain over...
Read More >